Proxy Access Rule 14a-11

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

l2007s

Rank: President [?]

Points: 18410 [?]

Votes: 123 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Proxy Access Rule 14a-11

posted on Mar 28, 2011 06:13PM

FYI

The litigation, Business Roundtable v. U.S. Securities and Exchange Commission is still pending resolution. Oral arguments are scheduled for April 7, 2011. For updated information, you may wish to monitor the website of the United States Court of Appeals for the District of Columbia Circuit at http://www.cadc.uscourts.gov/internet/home.nsf.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply